NOVASEQ
LIVE

Serial Number

87474750

Owner

Illumina Inc.

Attorney

Susan M. Natland

First Use Date

Jan 9, 2017

Filing Date

Jun 5, 2017

Add to watchlist:

No watchlists yet
View on USPTO

NOVASEQ Trademark

Serial Number: 87474750 • Registration: 6158457

NOVASEQ is a trademark filed by Illumina Inc. on June 5, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Illumina Inc.

5200 Illumina Way
San Diego, CA 92122

Entity Type: 03

Illumina, Inc. (3 trademarks)

5200 Illumina Way
San Diego, CA 92122

Entity Type: 03

Trademark Details

Filing Date

June 5, 2017

Registration Date

September 22, 2020

First Use Anywhere

January 9, 2017

First Use in Commerce

January 9, 2017

Published for Opposition

December 5, 2017

Goods & Services

Clinical and medical diagnostic instruments, namely, nucleic acid sequencers; scientific apparatus and instruments, namely, nucleic acid sequencers for medical and veterinary use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics

Providing on-line non-downloadable computer search engine software; providing online non-downloadable computer software for the custom design and ordering of assays, nucleic acids and reagents; software as a service (Saas), namely, hosting software for use by others for use in the custom design and ordering of assays, nucleic acids and reagents in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostic research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics; Nucleic acid sequencing and analysis services for scientific and research purposes; Genome sequencing and analysis services for scientific and research purposes; genetic analysis and reporting services for scientific and research purposes; installation and maintenance of computer software and database applications for others for use in the fields of nucleic acid sequencing and genotyping, medical diagnostics, clinical diagnostics, medical research, clinical research, life sciences, biology, drug development, drug development research, molecular diagnostics, laboratory medicine, biotechnology, agriculture, forensics, and genetics

Reagents, clinical diagnostic reagents, medical diagnostic assays for medical and diagnostic purposes, enzymes, nucleotides, buffers, chemical reagents, and biological preparations in the nature of human tissue or human body fluids, animal tissue or animal body fluids, cultures of microorganisms, or plant tissue for medical and veterinary use in the fields of medical diagnostics, veterinary diagnostics, laboratory medicine, veterinary medicine, and genetics

Computer hardware and computer software for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostic research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics; scientific apparatus and instruments, namely, nucleic acid sequencers for laboratory use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics

Reagents, assays, enzymes, chemical preparations, biological specimens in the nature of human tissue or human body fluid, animal tissue or animal body fluid, cultures of microorganisms, plant tissue and nucleotides for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, clinical research, drug development, drug development research, laboratory research, scientific research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, and genetics, not for medical or veterinary purposes; reagents kits comprised primarily of nucleotides, reagents, enzyme substrates, buffers, chemical preparations, biological preparations in the nature of human tissue or human body fluid, animal tissue or animal body fluid, cultures of microorganisms, plant tissue and enzymes for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, clinical research, drug development, drug development research, laboratory research, scientific and research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, and genetics, not for medical or veterinary purposes

Filing History

TEAS SECTION 8 & 15 RECEIVED
May 13, 2026 E815
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 29, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 29, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 29, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 29, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 29, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 29, 2025 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 22, 2025 REM1
EXPARTE APPEAL TERMINATED
Sep 22, 2020 EXPT
REGISTERED-PRINCIPAL REGISTER
Sep 22, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 21, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 20, 2020 CNPR
EXAMINER'S AMENDMENT ENTERED
Aug 20, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 20, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 20, 2020 GNEA
SU-EXAMINER'S AMENDMENT WRITTEN
Aug 20, 2020 SNEA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 18, 2020 ERFR
EX PARTE APPEAL-INSTITUTED
Aug 18, 2020 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 18, 2020 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Aug 18, 2020 EXAF
ATTORNEY REVIEW COMPLETED
Jul 28, 2020 ATRV
ATTORNEY REVIEW COMPLETED
Jul 15, 2020 ATRV
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 10, 2020 CHAN
ASSIGNED TO LIE
Jul 7, 2020 ALIE
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jun 25, 2020 EPPA
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 27, 2020 GNFN
FINAL REFUSAL E-MAILED
Feb 27, 2020 GNFR
SU - FINAL REFUSAL - WRITTEN
Feb 27, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 6, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 31, 2019 GNRN
NON-FINAL ACTION E-MAILED
Dec 31, 2019 GNRT
SU - NON-FINAL ACTION - WRITTEN
Dec 31, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 24, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 23, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 23, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 21, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 21, 2019 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 28, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jun 28, 2019 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jun 28, 2019 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jun 27, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 27, 2019 AITU
USE AMENDMENT FILED
Jun 14, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 14, 2019 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 29, 2019 EXRA
SOU EXTENSION 2 GRANTED
Jan 25, 2019 EX2G
SOU EXTENSION 2 FILED
Jan 25, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 25, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 31, 2018 EXRA
SOU EXTENSION 1 GRANTED
Jul 27, 2018 EX1G
SOU EXTENSION 1 FILED
Jul 27, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 27, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 30, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 5, 2017 NPUB
PUBLISHED FOR OPPOSITION
Dec 5, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 15, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 20, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 20, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 20, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 20, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 20, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 4, 2017 CRFA
ASSIGNED TO LIE
Oct 2, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 22, 2017 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Sep 21, 2017 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Sep 21, 2017 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Sep 21, 2017 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Sep 21, 2017 CPEA
ASSIGNED TO EXAMINER
Sep 5, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 10, 2017 NWOS
NEW APPLICATION ENTERED
Jun 8, 2017 NWAP